UNIPHARMA ApS: Financial statements 2024
CVR: 78881917
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -124,033
- Total Assets
- DKK 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | 0 | -124 t. | - |
| 2023 | - | 0 | 0 | -124 t. | 0 |
| 2022 | 0 | 0 | -88 | 56 t. | - |
| 2021 | - | - | -5 t. | 57 t. | - |
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
UNIPHARMA ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 0.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.